Patents Assigned to Sangamo BioScience, Inc.
  • Isolated mouse or human cell having an exogenous transgene in an endogenous albumin gene
    Patent number: 9255250
    Abstract: Cells and methods of using these cells for expressing a transgene expressing a protein that is aberrantly expressed in a metabolic disorders from a safe harbor locus.
    Type: Grant
    Filed: December 4, 2013
    Date of Patent: February 9, 2016
    Assignees: Sangamo BioScience, Inc., The Children's Hospital of Philadelphia
    Inventors: Philip D. Gregory, Katherine A. High
  • METHODS AND COMPOSITIONS FOR REGULATION OF TRANSGENE EXPRESSION
    Publication number: 20130177983
    Abstract: Nucleases and methods of using these nucleases for expressing a transgene from a safe harbor locus in a secretory tissue, and clones and animals derived therefrom.
    Type: Application
    Filed: September 21, 2012
    Publication date: July 11, 2013
    Applicant: Sangamo BioScience, Inc.
    Inventor: Sangamo BioScience, Inc.
  • Method for treating peripheral arterial disease with zinc finger proteins
    Publication number: 20090305977
    Abstract: Disclosed is a method for the administration of zinc finger proteins (ZFPs) or nucleic acids that encode such ZFPs for treating peripheral arterial disease, particularly by the repeated administration at regular intervals if such ZFPs or nucleic acids that encode such ZFPs.
    Type: Application
    Filed: February 9, 2007
    Publication date: December 10, 2009
    Applicant: Sangamo BioScience, Inc.
    Inventors: Patrice Tremble, Joe Rokovich, Brian Annex
  • Functional genomics using zinc finger proteins
    Patent number: 6599692
    Abstract: The present invention provides methods of regulating gene expression using recombinant zinc finger proteins, for functional genomics and target validation applications.
    Type: Grant
    Filed: September 14, 1999
    Date of Patent: July 29, 2003
    Assignee: Sangamo BioScience, Inc.
    Inventors: Casey C. Case, Lei Zhang